Cargando…
A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol
BACKGROUND: The number of youth living with HIV in the United States (US) continues to rise, and racial, ethnic, and sexual minority youth including young men who have sex with men (YMSM) and young transgender women (YTGW) bear a disproportionate burden of the HIV epidemic. Due to social and healthc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554516/ https://www.ncbi.nlm.nih.gov/pubmed/34715833 http://dx.doi.org/10.1186/s12889-021-12015-w |
_version_ | 1784591817713385472 |
---|---|
author | Wood, Olivia R. Garofalo, Robert Kuhns, Lisa M. Scherr, Thomas F. Zetina, Ana Paola Mata Rodriguez, Rafael Garibay Nash, Nathanael Cervantes, Marbella Schnall, Rebecca |
author_facet | Wood, Olivia R. Garofalo, Robert Kuhns, Lisa M. Scherr, Thomas F. Zetina, Ana Paola Mata Rodriguez, Rafael Garibay Nash, Nathanael Cervantes, Marbella Schnall, Rebecca |
author_sort | Wood, Olivia R. |
collection | PubMed |
description | BACKGROUND: The number of youth living with HIV in the United States (US) continues to rise, and racial, ethnic, and sexual minority youth including young men who have sex with men (YMSM) and young transgender women (YTGW) bear a disproportionate burden of the HIV epidemic. Due to social and healthcare system factors, many YMSM and YTGW do not seek HIV testing services and are therefore less likely to be aware that they are infected. Mobile health technology (mHealth) has the ability to increase uptake of HIV testing among these populations. Thus, the mLab App—which combines HIV prevention information with a mobile phone imaging feature for interpreting at-home HIV test results—was developed to improve testing rates and linkage to care among Black, Latino, and other YMSM and YTGW living in New York City and Chicago and their surrounding areas. METHODS: This study is a three-arm randomized controlled trial among YMSM and YTGW aged 18–29 years. Participants are randomized to either the mLab App intervention including HIV home test kits and standard of preventive care, standard of preventive care only, or HIV home test kits and standard of preventive care only. DISCUSSION: mHealth technology used for HIV prevention is capable of delivering interventions in real-time, which creates an opportunity to remotely reach users across the country to strengthen their HIV care continuum engagement and treatment outcomes. Specifically during the COVID-19 pandemic, mHealth technology combined with at-home testing may prove to be essential in increasing HIV testing rates, especially among populations at high-risk or without regular access to HIV testing. TRIAL REGISTRATION: This trial was registered with Clinicaltrials.gov (NCT03803683) on January 14, 2019. |
format | Online Article Text |
id | pubmed-8554516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85545162021-10-29 A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol Wood, Olivia R. Garofalo, Robert Kuhns, Lisa M. Scherr, Thomas F. Zetina, Ana Paola Mata Rodriguez, Rafael Garibay Nash, Nathanael Cervantes, Marbella Schnall, Rebecca BMC Public Health Study Protocol BACKGROUND: The number of youth living with HIV in the United States (US) continues to rise, and racial, ethnic, and sexual minority youth including young men who have sex with men (YMSM) and young transgender women (YTGW) bear a disproportionate burden of the HIV epidemic. Due to social and healthcare system factors, many YMSM and YTGW do not seek HIV testing services and are therefore less likely to be aware that they are infected. Mobile health technology (mHealth) has the ability to increase uptake of HIV testing among these populations. Thus, the mLab App—which combines HIV prevention information with a mobile phone imaging feature for interpreting at-home HIV test results—was developed to improve testing rates and linkage to care among Black, Latino, and other YMSM and YTGW living in New York City and Chicago and their surrounding areas. METHODS: This study is a three-arm randomized controlled trial among YMSM and YTGW aged 18–29 years. Participants are randomized to either the mLab App intervention including HIV home test kits and standard of preventive care, standard of preventive care only, or HIV home test kits and standard of preventive care only. DISCUSSION: mHealth technology used for HIV prevention is capable of delivering interventions in real-time, which creates an opportunity to remotely reach users across the country to strengthen their HIV care continuum engagement and treatment outcomes. Specifically during the COVID-19 pandemic, mHealth technology combined with at-home testing may prove to be essential in increasing HIV testing rates, especially among populations at high-risk or without regular access to HIV testing. TRIAL REGISTRATION: This trial was registered with Clinicaltrials.gov (NCT03803683) on January 14, 2019. BioMed Central 2021-10-29 /pmc/articles/PMC8554516/ /pubmed/34715833 http://dx.doi.org/10.1186/s12889-021-12015-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Wood, Olivia R. Garofalo, Robert Kuhns, Lisa M. Scherr, Thomas F. Zetina, Ana Paola Mata Rodriguez, Rafael Garibay Nash, Nathanael Cervantes, Marbella Schnall, Rebecca A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title | A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title_full | A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title_fullStr | A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title_full_unstemmed | A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title_short | A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol |
title_sort | randomized controlled trial of an mhealth intervention for increasing access to hiv testing and care among young cisgender men and transgender women: the mlab app study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554516/ https://www.ncbi.nlm.nih.gov/pubmed/34715833 http://dx.doi.org/10.1186/s12889-021-12015-w |
work_keys_str_mv | AT woodoliviar arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT garofalorobert arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT kuhnslisam arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT scherrthomasf arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT zetinaanapaolamata arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT rodriguezrafaelgaribay arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT nashnathanael arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT cervantesmarbella arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT schnallrebecca arandomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT woodoliviar randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT garofalorobert randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT kuhnslisam randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT scherrthomasf randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT zetinaanapaolamata randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT rodriguezrafaelgaribay randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT nashnathanael randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT cervantesmarbella randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol AT schnallrebecca randomizedcontrolledtrialofanmhealthinterventionforincreasingaccesstohivtestingandcareamongyoungcisgendermenandtransgenderwomenthemlabappstudyprotocol |